Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-κB inhibition

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 4, 2006, Pages 761-773

  Flati, Vincenzo ^a,e   Pastore, L I ^a   Griffioen, A W ^b   Satijn, S ^b   Toniato, E ^c   D'Alimonte, I ^c   Laglia, E ^a   Marchetti, P ^a   Gulino, A ^d   Martinotti, S ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CHIETI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Angiogenesis; bFGF; Endothelial cell anergy; ICAM 1; Mitogen activated protein kinase; Nuclear factor B; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; BASIC FIBROBLAST GROWTH FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE;

ARTICLE; CELL ACTIVATION; CLONAL ANERGY; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE ADHERENCE INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 33846433686     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900406     Document Type: Article

References (44)

1. Griffioen A.W., C.A. Damen, S. Martinotti, G.H. Blijham and G. Groenewegen. 1996 Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res. 56:1111.
2. Hellwig S.M., C.A. Damen, N.P. van Adrichem, G.H. Blijham, G. Groenewegen and A.W. Griffioen. 1997. Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors. Cancer Lett. 120:203.
3. Melder R.J., G.C. Koenig, B.P. Witwer, N. Safabakhsh, L.L. Munn and R.K. Jain. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2:992.
4. Griffioen A.W., C.A. Damen, G.H. Blijham and G. Groenewegen. 1996. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88:667.
5. Griffioen A.W., C.A. Damen, K.H. Mayo, A.F. Barendsz-Janson, S. Martinotti, G.H. Blijham and G. Groenewegen. 1999. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int. J. Cancer 80:315.
6. Tromp S.C., M.G. Oude Egbrink, R.P. Dings, S. van Velzen, D.W. Slaaf, H.F. Hillen, G.J. Tangelder, R.S. Reneman and A.W. Griffioen. 2000. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol. 12:671.
7. Yohn J.J., M. Critelli, M.B. Lyons and D.A. Norris. 1990. Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J. Invest. Dermatol 95:233.
8. Tessitore A., L. Pastore, A. Rispoli, L. Cilenti, E. Toniato, V. Flati, A.R. Farina, L. Frati, A. Gulino and S. Martinotti. 1998. Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-gamma. Eur. J. Biochem. 258:968.
9. Jahnke A. and J.P. Johnson. 1995. Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. Immunobiology 193:305.
10. Martinotti S., E. Toniato, A. Colagrande, E. Alesse, C. Alleva, I. Screpanti, S. Morrone, S. Scarpa, L. Frati, A.C. Hayday, et. al. 1995. Heavy-metal modulation of the human intercellular adhesion molecule (ICAM-1) gene expression. Biochim. Biophys. Acta 1261:107.
11. Voraberger G., R. Schafer and C. Stratowa. 1991. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J. Immunol. 147:2777.
12. Caldenhoven E., P. Coffer, J. Yuan, A. van de Stolpe, F. Horn, W. Kruijer and P.T. van der Saag. 1994. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269:21146.
13. Hou J., V. Baichwal and Z. Cao. 1994. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 91:11641.
14. Aoudjit F., M. Bosse, C. Stratowa, G. Voraberger and M. Audette. 1994. Regulation of intercellular adhesion molecule-1 expression by retinoic acid: analysis of the 5′ regulatory region of the gene. Int. J. Cancer. 58:543.
15. Huxford T., S. Malek and G. Ghosh. 1999. Structure and mechanism in NF-kappa B/I kappa B signaling. Cold Spring Harb. Symp. Quant. Biol. 64:533.
16. Delhase M. and M. Karin. 1999. The I kappa B kinase: a master regulator of NF-kappa B, innate immunity, and epidermal differentiation. Cold Spring Harb. Symp. Quant. Biol. 64:491.
17. Hiscott J., H. Kwon and P. Genin. 2001. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J. Clin. Invest. 107:143.
18. Tak P.P. and G.S. Firestein. 2001. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107:7.
19. Campbell K.J. and N.D. Perkins. 2006. Regulation of NF-kappaB function. Biochem. Soc. Symp. 73:165.
20. Kanda S., M.N. Hodgkin, R.J. Woodfield, M.J.O. Wakelam, G. Thomas and L. Claesson-Welsh. 1997. Phosphatidylinositol 3-Kinase-independent p70 S6 Kinase Activation by Fibroblast Growth Factor Receptor-1 Is Important for Proliferation but Not Differentiation of Endothelial Cells. J. Biol. Chem. 272:23347.
21. Ades E.W., F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, D.C. Bosse and T.J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol 99:683.
22. Pelle R. and N.B. Murphy. 1993. Northern hybridization: rapid and simple electrophoretic conditions. Nucleic. Acids Res. 21:2783.
23. Gorman C.M., L. F. Moffat and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
24. Eustice D.C., P.A. Feldman, A.M. Colberg-Poley, R.M. Buckery and R.H. Neubauer. 1991. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 11:739.
25. Flati V., S.J. Haque and B.R. Williams. 1996. Interferon-alpha- induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO J. 15:1566.
26. Vermeulen L., W. Vanden Berghe and G. Haegeman. 2006. Regulation of NF-kappaB transcriptional activity. Cancer Treat. Res. 130:89.
27. Stangl V., C. Gunther, A. Jarrin, P. Bramlage, M. Moobed, A. Staudt, G. Baumann, K. Stangl and S.B. Felix. 2001. Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-kappaB dependent pathway. Biochem. Biophys. Res. Commun. 280:1093.
28. Fernandes D.J., C.E. Ravenhall, T. Harris, T. Tran, R. Vlahos and A.G. Stewart. 2004. Contribution of the p38MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen-specific. Br. J. Pharmacol. 142(7):1182.
29. Schwenger P., D. Alpert, E.Y. Skolnik and J. Vilcek. 1998. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol. Cell. Biol. 18:78.
30. Alpert D., P. Schwenger, J. Han and J. Vilcek. 1999. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation. J. Biol. Chem. 274:22176.
31. Delehedde M., M. Seve, N. Sergeant, I. Wartelle, M. Lyon, P.S. Rudland and D.G. Fernig. 2000 Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and IkappaB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J. Biol. Chem. 275:33905.
32. Kozawa O., H. Tokuda, H. Matsuno and T. Uematsu. 1999. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J. Cell. Biochem. 74:479.
33. Maher P. 1999. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J. Biol. Chem. 274:17491.
34. Tanaka K., M. Abe and Y. Sato. 1999. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn. J. Cancer Res. 90:647.
35. Sa G., G. Murugesan, M. Jaye, Y. Ivashchenko and P.L. Fox. 1995. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270:2360.
36. Nugent M.A. and R.V. Iozzo. 2000. Fibroblast growth factor-2. Int. J. Biochem. Cell. Biol. 32:115.
37. Wong C.K., J.P. Zhang, W.K. Ip and C.W. Lam. 2002. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Clin. Exp. Immunol. 128:483.
38. Wesselborg S., M.K. Bauer, M. Vogt, M.L. Schmitz and K. Schulze-Osthoff. 1997. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272:12422.
39. Lasa M., K.R. Mahtani, A. Finch, G. Brewer, J. Saklatvala and A.R. Clark. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:4265.
40. Rossi A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin and M.G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403:103.
41. Straus D.S., G. Pascual, M. Li, J.S. Welch, M. Ricote, C.H. Hsiang, L.L. Sengchanthalangsy, G. Ghosh and C.K. Glass. 2000. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA 97:4844.
42. Rossi A., G. Elia and M.G. Santoro. 1997. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 94:746.
43. Xu X.C. 2002. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127.
44. Griffioen A.W., I.A.M. Relou, H.I. Gallardo Torres, C.A. Damen, S. Martinotti, J.C. de Graaf, J.J. Zwaginga and G. Groenewegen. 1998. The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions. Angiogenesis 2:235.